ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Information on distribution of medicines to pharmacies, other healthcare facilities and sellers of restricted medicinal products

The subject of reports by distributors includes supplies of medicines to pharmacies, other healthcare facilities, and also to sellers of restricted drugs with regard to restricted medicinal products, also supplies of medicinal products for human use to veterinarians authorised to perform specialised activity, which SUKL also monitors based on the instruction DIS-13, the current version, within monitoring of supplies of medicines. The reports include supplies of medicinal products outside ČR, including mutual trading with foreign distributors. The data also includes information on specific treatment programs.    

The information includes exclusively data from distributor reports according to the instruction of SUKL DIS-13, the current version, on distribution of medicines; this is not actual consumption by patients, i.e. data describing specific dispensing to patients

Distribution of medicines

Of the total number of 59,884 registered variants* of medicines (of which 3,263 homeopathics) (as of 1 April, 2012), the following was supplied to the network of healthcare facilities in the 1st quarter of 2012:

  • 7,863 variants of medicines (i.e. 13.13% of the total number of registered variants) (399 homeopathics)
  • of which 5,603 variants of supplied medicines has determined payment via health insurance (i.e. 71.26% of the number of tradable variants of medicines)

*A variant of a medicine shall be understood as a medicine identifiable by a SUKL code allocated separately to every medicine, taking into account the efficacy, size of package and form of the medicine.

 

Comparison of information on distribution of medicines in DDD, financial figures and number of packages

Distribution to the network of healthcare facilities in ČR   
Year Q DDD* total (million) Packages (million units) Financial volume in prices of the entity of origin (CZK bn)
2007 1 1 362,21 88,23 11,934
2007 2 1 377,67 82,79 12,500
2007 3 1 256,08 78,04 11,613
2007 4 1 606,37 94,09 14,066
2008 1 1 226,80 83,30 12,990
2008 2 1 301,12 78,94 13,150
2008 3 1 823,24 77,70 12,962
2008 4 1 311,78 77,73 13,753
2009 1 1 324,39 83,54 14,224
2009 2 1 377,27 76,51 14,918
2009 3 1 272,65 73,94 14,244
2009 4 1 298,89 77,94 14,851
2010 1 1 487,71 80,44 14,998
2010 2 1 524,24 76,64 15,085
2010 3 1 346,72 71,81 13,982
2010 4 1 448,35 75,48 14,780
2011 1 1 520,81 80,80 15,208
2011 2 1 534,25 74,96 15,343
2011 3 1 366,38 68,37 13,664
2011 4 1 450,48 72,95 14,505
2012 1 1 556,11 76,05 15,561

* DDD values are calculated using the values valid in the respective period.  

The total number of 76.05 million distributed packages includes:

  • Medicines the dispensing of which requires a medical prescription
    • Number of packages – 50.95 million units (total of 1,411.15 million DDD). This is almost 67% of the total number of supplied packages of medicines.
    • Financial value in the prices of the entity of origin – CZK 13.482 bn, which represents 86.64 % of the total financial volumes. 
  • Medicines which may be dispensed without a medical prescription with a restriction
    • Number of packages – 0.199 million units (total of 0.179 million DDD). This is 0.26% of the total number of supplied packages of medicines.
    • Financial value in the prices of the entity of origin – CZK 21.363 Mio, which represents 0.14% of the financial volumes
  • Medicines which may be dispensed without medical prescription
    • Number of packages – 23.23 million units (total of 143.522 million DDD). This is almost 30.54% of the total number of supplied packages of medicines.
    • Financial value in the prices of the entity of origin - CZK 1.56 bn, which represents 10.05 % of the total financial volumes. 
  • Medicines for rare illnesses (“orphan”)
    • Number of packages – 17,236 units. This is 0.023% of the total number of supplied packages of medicines.
    • Financial value in the prices of the entity of origin – CZK 438.484 Mio, which represents 2.82% of the financial volumes. 
  • Medicines supplied to veterinarians
    • Number of packages – 261,058 units.       
    • Financial value in the prices of the entity of origin – CZK 16.93 Mio.       
  • Medicines used within specific treatment programs approved by the Ministry of Health
    • Number of packages – 78,152 units. This is 0.10% of the total number of supplied packages of medicines.
    • Financial value in the prices of the entity of origin – CZK 17.50 Mio, which represents 0.11% of the financial volumes.

 

Assessment of distribution activity

As of 1 January, 2011, the report on supplies of medicines for human use is sent in accordance with the instruction DIS13, version 4.

In the 1st quarter of 2012, the number of entities with the distribution licence was the following: January 419, February 422, March 418. Distribution accounts were established for the entities and used by them to submit reports on medicine supplies.

 January 2012: 566 distribution accounts, of which

  • 558 submitted the reports, of which
    • 122 did not distribute
    • 436 distributed
  •  6 did not submit the reports
  •  2 end

February 2012: 570 distribution accounts, of which

  • 562 submitted the reports, of which
    • 127 did not distribute
    • 435 distributed
  • 5 did not submit the reports
  • 3 end

March 2012: 575 distribution accounts, of which

  • 555 submitted the reports, of which
    • 123 did not distribute
    • 432 distributed
  • 12 did not submit the reports
  • 8 end

The Supervisory Section investigated the entities that did not submit their reports within the stipulated deadline.